Dr. Linehan is CEO of the University of Rochester Medical Center (URMC), dean of the School of Medicine and Dentistry (SMD), and senior vice president for Health Sciences at the University of Rochester. Before that, he chaired URMC’s Department of Surgery for 10 years. A surgical oncologist and an accomplished researcher, Dr. Linehan is recognized for bringing new therapies to patients with difficult-to-treat cancers, and for his compassionate approach to care. He is also internationally renowned for his research into new immunotherapy treatments for pancreatic cancer; his laboratory has been continuously funded by the National Cancer Institute for nearly two decades. He specializes in treating cancers and benign surgical conditions of the liver, pancreas, gallbladder, and bile ducts.
Dr. Linehan attended Dartmouth College, graduated from the University of Massachusetts Medical School, then completed his internship and residency at Deaconess-Harvard Surgical Service. He was a research fellow at Brigham and Women’s Hospital and the Kristin Ann Carr Fellow in Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He went on to become a professor of Surgery at Washington University and chief of Hepatobiliary, Pancreatic and Gastrointestinal Surgery.